Cytosorbents (NASDAQ:CTSO) Receives “Neutral” Rating from HC Wainwright

Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They presently have a $1.00 price objective on the medical research company’s stock. HC Wainwright’s target price would suggest a potential upside of 3.09% from the company’s previous close. […]